Spontaneous Orbital Hemorrhage in Pregnant Women Treated With Subcutaneous Heparin

• Published in: American journal of ophthalmology Vol. 122; no. 6; pp. 907 - 908
• Main Authors: Chang, Warren J., Nowinski, Thaddeus S., Repke, Carolyn S., Buerger, David G.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01-12-1996; Elsevier; Elsevier Limited
• Subjects: Adult; Anticoagulants - adverse effects; Anticoagulants - therapeutic use; Biological and medical sciences; Drug toxicity and drugs side effects treatment; Female; Heparin - adverse effects; Heparin - therapeutic use; Humans; Injections, Subcutaneous; Magnetic Resonance Imaging; Medical sciences; Pharmacology. Drug treatments; Phlebitis - therapy; Pregnancy; Retrobulbar Hemorrhage - diagnosis; Retrobulbar Hemorrhage - etiology; Toxicity: eye; Vision Disorders - etiology; Human; Toxicity; Cardiovascular disease; Orbit(eye) disease; Anticoagulant; Orbit(eye); Hemorrhage; Vascular disease; Case study; Pregnancy; Chemotherapy; Treatment; Glycosaminoglycan; Subcutaneous administration; Heparin
• ISSN: 0002-9394; 1879-1891
• DOI: 10.1016/S0002-9394(14)70399-X

To describe two pregnant women who developed spontaneous orbital hemorrhage following treatment with subcutaneous heparin.
Case histories and subsequent management of spontaneous orbital hemorrhage.
Both women developed severe unilateral visual loss.
In spontaneous orbital hemorrhage, anticoagulation therapy such as heparin may contribute to severe hemorrhage and visual loss.